Amexdrug Stock Current Liabilities
| AXRX Stock | USD 0 0.00 0.00% |
Amexdrug fundamentals help investors to digest information that contributes to Amexdrug's financial success or failures. It also enables traders to predict the movement of Amexdrug Pink Sheet. The fundamental analysis module provides a way to measure Amexdrug's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amexdrug pink sheet.
Amexdrug |
Amexdrug Company Current Liabilities Analysis
Amexdrug's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Amexdrug Current Liabilities | 798 K |
Most of Amexdrug's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amexdrug is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Amexdrug has a Current Liabilities of 798 K. This is 99.95% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 99.99% higher than that of the company.
Amexdrug Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amexdrug's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amexdrug could also be used in its relative valuation, which is a method of valuing Amexdrug by comparing valuation metrics of similar companies.Amexdrug is currently under evaluation in current liabilities category among its peers.
Amexdrug Fundamentals
| Return On Equity | 0.29 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 34.51 M | |||
| Shares Outstanding | 169.11 M | |||
| Price To Earning | 165.00 X | |||
| Price To Book | 51.38 X | |||
| Price To Sales | 3.04 X | |||
| Revenue | 10.43 M | |||
| Gross Profit | 1.01 M | |||
| EBITDA | 380.83 K | |||
| Net Income | 111.36 K | |||
| Cash And Equivalents | 168.01 K | |||
| Total Debt | 961.12 K | |||
| Debt To Equity | 1.46 % | |||
| Current Ratio | 1.35 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | 27.49 K | |||
| Beta | -0.72 | |||
| Market Capitalization | 16.91 M | |||
| Total Asset | 2.31 M | |||
| Retained Earnings | 961 K | |||
| Working Capital | 966 K | |||
| Current Asset | 1.76 M | |||
| Current Liabilities | 798 K | |||
| Z Score | 14.2 | |||
| Net Asset | 2.31 M |
About Amexdrug Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amexdrug's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amexdrug using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amexdrug based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Amexdrug Pink Sheet Analysis
When running Amexdrug's price analysis, check to measure Amexdrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amexdrug is operating at the current time. Most of Amexdrug's value examination focuses on studying past and present price action to predict the probability of Amexdrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amexdrug's price. Additionally, you may evaluate how the addition of Amexdrug to your portfolios can decrease your overall portfolio volatility.